Israel’s Oramed (reported here previously) has launched Oravax – a joint venture with India’s Premas Biotech to develop a Covid-19 vaccine. The vaccine is administered orally (not injected) and targets 3 virus proteins, so should counter any mutations. Human trials expected soon.

https://www.oramed.com/oramed-forms-a-joint-venture-oravax-medical-inc-for-the-development-of-novel-oral-covid-19-vaccines/

https://www.youtube.com/watch?v=lQXaylnGXLM